Assessment of Device for Treatment of Amblyopia

Not Applicable

Completed

• Conditions: Amblyopia

• Registration Number: NCT02003235
• Lead Sponsor: Visior Technologies Ltd.

Brief Summary

The study will evaluate the effect of Reviview™, a dichoptic video display device for administrating a novel treatment protocol for Amblyopia (lazy eye) in kids.

The effect of the treatment will be measured by the change from baseline in Visual acuity and in Stereoscopic Vision; and to assess the ease of use of and compliance by the patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2013-10
• Study First Submitted: 2013-12-01
• Study First Submitted QC: 2013-12-01
• Study First Posted: 2013-12-06
• Status Verified: 2017-07
• Primary Completion: 2017-07-15
• Study Completion: 2017-07-15
• Last Update Submitted: 2017-07-18
• Last Update Posted: 2017-07-21

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 35

Inclusion Criteria

Refractive or Strabismic Amblyopia, with best corrected visual acuity.

(1) Refractive Amblyopia, visual acuity score <6:15 (worse then)

• or (2) Strabismic Amblyopia, visual acuity score between 6:15 and 6:30

Exclusion Criteria

Diagnosed with epilepsy, recently treated with occlusion or penalization therapy

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Improvement in VA in amblyopic eye	3 months

Trial Locations

Locations (1)

Tel-Aviv Sourasky Medical Center; 🇮🇱 Tel-Aviv, Israel